性行為感染傳染病（STD）診斷檢測市場：按檢測類型和地區分類 -

Diagnostic Testing of STDs Market, By Test Type (Chlamydia, Gonorrhea, Syphilis, HIV, HPV+pap smear, HSV, and Chancroid), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，性行為感染(STI) 診斷檢測市場規模將達到 137.1 億美元，到 2033 年將達到 263.9 億美元。預計從 2026 年到 2033 年，該市場將以 9.8% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	137.1億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.80%	2033年市場規模預測：	263.9億美元

性行為感染感染（STI）是指透過性接觸在人與人之間傳播的疾病。早期發現或診斷性行為感染可以防止感染進一步擴散。臨床檢測，例如血液檢查、尿液檢查、拭子檢查、腰椎穿刺和體液檢查，可以確定原因並檢測合併感染疾病。篩檢是對無症狀個體進行疾病檢測的過程。篩檢可以針對多種感染疾病，包括愛滋病毒、B型肝炎、披衣菌感染、梅毒、淋病和C型肝炎。子宮頸癌通常由特定類型的人類乳突病毒（HPV）引起。抗生素和抗病毒藥物用於治療性行為感染，可以防止疾病進一步傳播。

市場動態

性行為感染）的日益普及以及政府對其治療和管理的投入預計將推動全球性行為感染診斷檢測市場的成長。例如，2023年2月2日，總部位於印度的生物技術公司Mylab Discovery Solutions Pvt. Ltd.推出了用於檢測套組包括人類免疫力缺乏病毒（HIV）、C型肝炎病毒（HCV）和梅毒在內的多種性行為感染的快速檢測試劑盒。其中，HIV 1/2抗體檢測和HCV抗體檢測分別是檢測HIV-1、HIV-2和HCV特異性抗體的快速檢測，而梅毒抗體檢測則是檢測用於輔助診斷梅毒的抗體（IgG、IgA和IgM）。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數介紹了全球性行為感染感染 (STI) 診斷檢測市場主要參與者的概況：公司亮點、產品系列、主要特點、財務績效和策略。
本研究涵蓋的主要公司包括 Vela Diagnostics USA Inc.、Roche Holdings AG、Alere, Inc.、Becton Dickinson & Company、bioMerieux、Danaher Corporation (Beckman Coulter)、Hologic, Inc.、binx health、Chembio Diagnostics、Pinpoint Science Inc. 和 bioLytical Laboratories。
本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
這份《全球性行為感染傳染病（STD）診斷檢測市場》報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
相關人員可以透過利用分析全球性行為感染(STI) 診斷檢測市場中使用的各種策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第6章競爭情勢

Vela Diagnostics USA Inc.
Roche Holdings AG
Alere, Inc.
Becton Dickinson & Company
bioMerieux
Danaher Corporation（Beckman Coulter）
Hologic, Inc.
binx health
Chembio Diagnostics
Pinpoint Science Inc.
bioLytical Laboratories

第7章

調查方法
關於本公司

簡介目錄

Product Code: CMI3917

Diagnostic Testing Of Stds Market is estimated to be valued at USD 13.71 Bn in 2026 and is expected to reach USD 26.39 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 13.71 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.80%	2033 Value Projection:	USD 26.39 Bn

Sexually Transmitted Diseases (STDs) are diseases that spread from person-to-person through sexual contact. Early identification or diagnosis of STDs can help stop further transmission. Laboratory tests can identify the cause and detect co-infections through blood tests, urine samples, swab tests, lumbar puncture, and fluids samples. Testing for a disease in someone who doesn't have symptoms is called screening. The screening can be done for a variety of infections like HIV, hepatitis B, chlamydia, syphilis, gonorrhea, and hepatitis C. Cervical cancer is often caused by certain strains of HPV. Treatment of STDs can be done by antibiotics and antiviral drugs which prevents the further spread of disease.

Market Dynamics

The increasing prevalence of STDs, government fundings for the treatment and management of STDs is expected to drive the global diagnostic testing of STDs market growth. For instance, on February 2, 2023, Mylab Discovery Solutions Pvt. Ltd., an India-based biotechnology company, launched rapid test kits for sexually transmitted diseases including human immunodeficiency virus (HIV), Hepatitis C virus (HCV), and syphilis. Among these tests, HIV 1/2 Ab, and HCV Ab are rapid tests for the detection of antibodies specific to HIV-1, HIV-2, and HCV respectively, while the syphilis antibody test detects antibodies (IgG, IgA, and IgM) to aid in the diagnosis of syphilis.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global diagnostic testing of STDs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics.
The global diagnostic testing of STDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic testing of STDs market.

Market Segmentation

Global Diagnostic Testing of STDs Market, By Test Type (Revenue, USD Bn, 2021 - 2033)
Chlamydia
Gonorrhea
Syphilis
HIV
HPV+pap smear
HSV
Chancroid
Global Diagnostic Testing of STDs Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- North Africa
- Central Africa
- South Africa
Company Profiles
Vela Diagnostics USA Inc.
Roche Holdings AG
Alere, Inc.
Becton Dickinson & Company
bioMerieux
Danaher Corporation (Beckman Coulter)
Hologic, Inc.
binx health
Chembio Diagnostics
Pinpoint Science Inc.
bioLytical Laboratories.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Diagnostic Testing of STDs Market, By Test Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Chlamydia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Gonorrhea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Syphilis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
HPV+ pap smear
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
HSV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Chancroid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Diagnostic Testing of STDs Market, By Region, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021-2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

6. Competitive Landscape

Vela Diagnostics USA Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Roche Holdings AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Alere, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Becton Dickinson & Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
bioMerieux
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Danaher Corporation (Beckman Coulter)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
binx health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chembio Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pinpoint Science Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
bioLytical Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies